LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
January 13, 2010 (Miami, Florida) — Carotid artery (CA) cannulation for veno-arterial extracorporeal membrane oxygenation (ECMO) is associated with a higher risk for central nervous system (CNS) ...
A new study found that the first four months of the Minnesota Mobile Resuscitation Consortium (MMRC) was 100% effective in cannulation for out-of-hospital sudden cardiac arrests. Cannulation is when ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For ...
Over the past three years, the Minnesota Mobile Resuscitation Consortium (MMRC) at the University of Minnesota has been working on the development of a medical truck aimed at delivering mobile ...
Pediatr Crit Care Med. 2016;17(S1):S155-S159. The above reports illustrate poor survival in patients with single ventricle congenital heart disease requiring ECMO. Given that ECMO utilization in this ...
To describe the use of double-lumen venovenous (VVDL) extracorporeal membrane oxygenation (ECMO) with cephalic draining cannula (VVDL+V) as a primary approach for all neonatal respiratory diagnoses ...
Please provide your email address to receive an email when new articles are posted on . Among patients receiving extracorporeal membrane oxygenation, the presence of obesity did not impact mortality ...
Please provide your email address to receive an email when new articles are posted on . Patients with severe COVID-19 who received venovenous extracorporeal membrane oxygenation support had ...
Neonates were monitored with a cerebral oximeter before, during, and after cannulation for ECMO to determine the direct effects of ligation of the right internal jugular vein and right carotid artery ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...